Stock listing
REGN34 Stock Price, News, Filings & Events — Regeneron Pharmaceuticals, Inc.
Selected listing: REGN34 · BMFBOVESPA · BRL · BR
This page tracks Regeneron Pharmaceuticals, Inc.'s REGN34:BMFBOVESPA listing on BMFBOVESPA in BRL for BR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following REGN34:BMFBOVESPA. REGN34:BMFBOVESPA is the stock-level entry point for investors researching Regeneron Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- REGN34:BMFBOVESPA
- Asset type
- Stock
- Market cap
- $80.80B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- BMFBOVESPA
- Currency
- BRL
Regeneron Pharmaceuticals, Inc. REGN34:BMFBOVESPA stock context
This page tracks Regeneron Pharmaceuticals, Inc.'s REGN34:BMFBOVESPA listing on BMFBOVESPA in BRL for BR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following REGN34:BMFBOVESPA. REGN34:BMFBOVESPA is the stock-level entry point for investors researching Regeneron Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Regeneron Pharmaceuticals, Inc.
Students Earn Top Awards at CEE’s 43rd Annual Research Science Institute at MIT
August 26, 2026
Veeva Vault CRM Selected by Regeneron
August 25, 2026
Pasatru™ (garetosmab-grts) First and Only FDA-approved Treatment Demonstrating Reduction in New Heterotopic Ossification (HO) Lesions and Clinician-Assessed Flare-ups in a Placebo-controlled Trial in Adults with Fibrodysplasia Ossificans Progressiva (FOP)
August 19, 2026
Regeneron Awards $150,000 to Winners of the 2026 Regeneron Prize for Creative Innovation
July 31, 2026
Regeneron Reports Second Quarter 2026 Financial and Operating Results
July 30, 2026
Regeneron Pharmaceuticals, Inc. earnings calls
Regeneron Pharmaceuticals, Inc. (REGN) Q2 2026 Earnings Call
July 30, 2026 · Replay with transcript and chapters
Regeneron Pharmaceuticals, Inc. (REGN) Q1 2026 Earnings Call
April 29, 2026 · Replay with transcript and chapters
Regeneron Pharmaceuticals, Inc. (REGN) Q4 2025 Earnings Call
January 30, 2026 · Replay with transcript and chapters
Regeneron Pharmaceuticals, Inc. (REGN) Q3 2025 Earnings Call
October 28, 2025 · Replay with transcript and chapters
Regeneron Pharmaceuticals, Inc. (REGN) Q2 2025 Earnings Call
August 1, 2025 · Replay with transcript and chapters
Regeneron Pharmaceuticals, Inc. (REGN) Q1 2025 Earnings Call
April 29, 2025 · Replay with transcript and chapters
Research Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. investor report
Review AI stock analysis and investor report context for REGN34:BMFBOVESPA.
Regeneron Pharmaceuticals, Inc. company profile
View the public company page for Regeneron Pharmaceuticals, Inc. on 6ix.
Regeneron Pharmaceuticals, Inc. news
Read company news and market updates connected to Regeneron Pharmaceuticals, Inc..
Regeneron Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Regeneron Pharmaceuticals, Inc..
Alternate listings
REGN:NASDAQ
US · USD
Alternate listing for Regeneron Pharmaceuticals, Inc.; the primary context on this page is REGN34:BMFBOVESPA.
RGO:GETTEX
DE · EUR
Alternate listing for Regeneron Pharmaceuticals, Inc.; the primary context on this page is REGN34:BMFBOVESPA.
881535:LSX
DE · EUR
Alternate listing for Regeneron Pharmaceuticals, Inc.; the primary context on this page is REGN34:BMFBOVESPA.
RGO:TRADEGATE
DE · EUR
Alternate listing for Regeneron Pharmaceuticals, Inc.; the primary context on this page is REGN34:BMFBOVESPA.
REGN:BMV
MX · MXN
Alternate listing for Regeneron Pharmaceuticals, Inc.; the primary context on this page is REGN34:BMFBOVESPA.
REGN:BOATS
US · USD
Alternate listing for Regeneron Pharmaceuticals, Inc.; the primary context on this page is REGN34:BMFBOVESPA.
RGO:FWB
DE · EUR
Alternate listing for Regeneron Pharmaceuticals, Inc.; the primary context on this page is REGN34:BMFBOVESPA.
0R2M:LSE
GB · USD
Alternate listing for Regeneron Pharmaceuticals, Inc.; the primary context on this page is REGN34:BMFBOVESPA.
881535:LS
DE · EUR
Alternate listing for Regeneron Pharmaceuticals, Inc.; the primary context on this page is REGN34:BMFBOVESPA.
RGO:DUS
DE · EUR
Alternate listing for Regeneron Pharmaceuticals, Inc.; the primary context on this page is REGN34:BMFBOVESPA.
REGN:VIE
AT · EUR
Alternate listing for Regeneron Pharmaceuticals, Inc.; the primary context on this page is REGN34:BMFBOVESPA.
REGN:BIVA
MX · MXN
Alternate listing for Regeneron Pharmaceuticals, Inc.; the primary context on this page is REGN34:BMFBOVESPA.